CPRT has enrolled participants into clinical studies for many different health indications, including:

 

Type 1 Diabetes Mellitus:

• New formulas of insulin

• Oral medications (tablets)

• Portable meters and insulin pumps

• Paediatric studies

• Family Screening and Prevention studies

• Retinopathy

 

Type 2 Diabetes Mellitus (Phases 2-4):

• Oral medications (including DPP-4 inhibitors, SGLT 1 and 2 inhibitors)

• Injectable medications (New insulin formulas, GLP-1 agonists, novel metabolic agents)

• Implant studies- new delivery systems for registered medications

• Weight loss studies

• Nephropathy (mild, moderate and severe)

• Meter studies

 

Cardiology:

• Hypertension

• Heart Failure (reduced ejection fraction)

 

Hyperlipidaemia (Phase 2 and 3):

• Familial Hyperlipidaemia (including apheresis patients)

• High triglycerides

• Combined dyslipidaemia

• Statin-intolerant

 

Respiratory Health:

• Chronic Obstructive Pulmonary Disease/Emphysema

• Asthma

• Prevention of respiratory infections in over 65 year olds

 

Dermatology:

• Eczema

• Infections

 

Geriatric population (≥ 65years:)

• Immune system

• Healthy aging and general wellbeing

• Vaccine response

• Prevention of infections

 

Long-term Health Outcome Trials assessing Cardiovascular, Renal, or Bone Health Outcomes:

• Diabetic medications

• Heart Failure medications

• Lipid-Lowering medications